Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD

about

Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD

Item

http://www.wikidata.org/entity/Q58765669

description

im September 2018 veröffentlicher wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Chitosan-functionalized lipid- ...... lipid-lowering effect in NAFLD

@en

Chitosan-functionalized lipid- ...... lipid-lowering effect in NAFLD

@nl

type

Item

label

Chitosan-functionalized lipid- ...... lipid-lowering effect in NAFLD

@en

Chitosan-functionalized lipid- ...... lipid-lowering effect in NAFLD

@nl

prefLabel

Chitosan-functionalized lipid- ...... lipid-lowering effect in NAFLD

@en

Chitosan-functionalized lipid- ...... lipid-lowering effect in NAFLD

@nl

P1476

Chitosan-functionalized lipid- ...... lipid-lowering effect in NAFLD

@en

P2093

Fei Yan

http://www.w3.org/2001/XMLSchema#string

Jinguang Liu

http://www.w3.org/2001/XMLSchema#string

Jun Liang

http://www.w3.org/2001/XMLSchema#string

Peiwen Huang

http://www.w3.org/2001/XMLSchema#string

Qiangyuan Fan

http://www.w3.org/2001/XMLSchema#string

Ying Liu

http://www.w3.org/2001/XMLSchema#string

Zhe Li

http://www.w3.org/2001/XMLSchema#string

Zhi Wang

http://www.w3.org/2001/XMLSchema#string

Zifei Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

Anti-obese effect of glucosamine and chitosan oligosaccharide in high-fat diet-induced obese rats.

Modulation of lipid metabolism by mixtures of protamine and chitooligosaccharide through pancreatic lipase inhibitory activity in a rat model.

Chitosan-based particles as controlled drug delivery systems.

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.

Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.

Hepatoprotective effect of silymarin.

Serum TAG analysis differentiates between genetic and obesity-associated NAFLD

P2888

s12951-018-0391-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12951-018-0391-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nianping Feng

P577

2018-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106525599

http://www.w3.org/2001/XMLSchema#string

P698

30176941

http://www.w3.org/2001/XMLSchema#string

P921

biomedical engineering

molecular medicine

bioengineering

P932

6122632

http://www.w3.org/2001/XMLSchema#string